Rigel Pharmaceuticals (RIGL) Posts Wider than Expected Q4 Loss of 36c/Share

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY

6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT

Price: $1.10 -2.65%

EPS Growth %: +62.5%

Financial Fact:
Interest income: 110K

Today's EPS Names:
FRSB, DGICA, UXIN, More

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q4 EPS of ($0.36), $0.08 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!